WASHINGTON (AP) Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.
Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections
Pfizer and Merck's COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role.
COVID-19 pill rollout stymied by shortages as omicron rages netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.